The Peptide Addict is an independent peptide intelligence platform.
We are not a vendor. We are not a clinic. We are not a guru brand selling coaching or protocols. We are a reference library and newsroom covering peptides for adults who want clarity before they buy, inject, or believe.
What we do
We separate four things that usually get collapsed into one:
- Evidence — what human data actually exists?
- Safety — what are the known and unknown risks?
- Legal and access reality — approved, compounded, research-use, or gray?
- Market integrity — who profits from the story, and where are incentives distorting the narrative?
Every major article carries a visible scorecard across six dimensions, including a metric we call hype gap — how far public enthusiasm exceeds the quality of evidence.
What we cover
- Peptide Profiles — canonical pages on specific compounds.
- Comparisons — side-by-side analysis of compounds people actually have to choose between.
- Regulatory Watch — legal and access changes as they happen.
- Vendor Intelligence — methodology-driven reviews, not affiliate funnels.
- Research Desk — study summaries, evidence updates, myth checks.
- Guides — beginner-oriented reference content.
What we refuse to do
Because our only moat is trust, a short list of things you will not find on The Peptide Addict:
- Underground dosing guides
- "Where to buy cheap peptides" bait content
- Sponsored content disguised as editorial
- Coaching or protocol services that would compromise editorial neutrality
- Sourcing help in DMs
- Personalized medical advice
If you want those things, other sites offer them. We think the category needs something different, and that's what we're building.
How to read The Peptide Addict
Our house stance on most compounds is the same: interesting signal, incomplete evidence, real demand, mixed incentives, proceed with clarity.
We are not anti-peptide. Several compounds in this category have strong evidence and real clinical utility. We are anti-sloppy-thinking about peptides, and we try to be very clear about the difference.
Related pages
- Methodology — how we evaluate evidence and score compounds.
- Editorial Policy — the rules that govern what we publish.
- Affiliate Disclosure — how we handle commercial relationships.
- Newsletter — weekly peptide intelligence.